Beam Therapeutics Inc. financial data

Symbol
BEAM on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
26 Landsdowne Street, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 585 % +18.5%
Debt-to-equity 48.4 % -33.2%
Return On Equity -16.2 % +60.1%
Return On Assets -10.9 % +53.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 82.8M shares +1.6%
Common Stock, Shares, Outstanding 82.6M shares +4%
Entity Public Float 2.11B USD -14.2%
Common Stock, Value, Issued 826K USD +4.03%
Weighted Average Number of Shares Outstanding, Basic 82.4M shares +4.28%
Weighted Average Number of Shares Outstanding, Diluted 82.4M shares +4.28%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 350M USD +329%
Research and Development Expense 406M USD +5.88%
General and Administrative Expense 126M USD +31.1%
Operating Income (Loss) -183M USD +54.1%
Nonoperating Income (Expense) 40.5M USD -52.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -96.7M USD -0.6%
Income Tax Expense (Benefit) 1.41M USD -58.8%
Net Income (Loss) Attributable to Parent -144M USD +54.2%
Earnings Per Share, Basic -1.58 USD/shares +62.1%
Earnings Per Share, Diluted -1.58 USD/shares +62.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 230M USD +36.2%
Marketable Securities, Current 696M USD -17.8%
Cash, Cash Equivalents, and Short-term Investments 926M USD -7.42%
Assets, Current 946M USD -9.04%
Property, Plant and Equipment, Net 114M USD -11%
Operating Lease, Right-of-Use Asset 105M USD -6.63%
Other Assets, Noncurrent 1.08M USD -59.4%
Assets 1.17B USD -9.23%
Accounts Payable, Current 3.81M USD +20%
Employee-related Liabilities, Current 13.7M USD -0.19%
Contract with Customer, Liability, Current 89.3M USD -41.8%
Liabilities, Current 166M USD -24.6%
Contract with Customer, Liability, Noncurrent 57.8M USD -53.6%
Operating Lease, Liability, Noncurrent 149M USD -7.16%
Other Liabilities, Noncurrent 481K USD -54.1%
Liabilities 380M USD -25.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.76M USD
Retained Earnings (Accumulated Deficit) -1.48B USD -10.8%
Stockholders' Equity Attributable to Parent 791M USD +1.59%
Liabilities and Equity 1.17B USD -9.23%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -99.7M USD +9.17%
Net Cash Provided by (Used in) Financing Activities 2.9M USD -97.1%
Net Cash Provided by (Used in) Investing Activities -53.5M USD -310%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 82.6M shares +4%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -150M USD -1170%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 237M USD +33.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 14K USD -77.4%
Deferred Tax Assets, Valuation Allowance 329M USD +29.5%
Deferred Tax Assets, Gross 366M USD +23.3%
Operating Lease, Liability 173M USD -3.53%
Depreciation 21.8M USD +17.5%
Payments to Acquire Property, Plant, and Equipment 2.44M USD -59.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -140M USD +55%
Lessee, Operating Lease, Liability, to be Paid 251M USD -6.22%
Property, Plant and Equipment, Gross 180M USD +4.54%
Operating Lease, Liability, Current 12.9M USD +8.24%
Lessee, Operating Lease, Liability, to be Paid, Year Two 25.3M USD +3.53%
Lessee, Operating Lease, Liability, to be Paid, Year One 25M USD +15.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 78.6M USD -11.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 22.5M USD -10%
Deferred Tax Assets, Operating Loss Carryforwards 3.96M USD -84.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 23.2M USD +4.21%
Operating Lease, Payments 19.1M USD +66.2%
Additional Paid in Capital 2.27B USD +7.2%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 5.43M USD +16.9%
Share-based Payment Arrangement, Expense 113M USD +14.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%